Polaryx Therapeutics: Funding, Investors & Team (Oct 2026)
Polaryx Therapeutics is a biotechnology company that focuses on developing treatments for diseases. The company conducts research to discover new drugs and therapies. It works on understanding the biology of different health conditions to find effective solutions. The company uses laboratory techniques and clinical studies to test its potential treatments. It aims to improve health outcomes through scientific advancements.
Polaryx Therapeutics has raised $10.0M across 1 funding round on record, the most recent an undisclosed round of $10.0M announced in May 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Polaryx Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2026.
Polaryx Therapeutics Funding Rounds
Polaryx Therapeutics Founders and Leadership Team
Contact details for the Polaryx Therapeutics team: 1 has a LinkedIn profile.
Start 14-day free trial →Polaryx Therapeutics Funding Compared to Other Biotechnology Startups
Polaryx Therapeutics' latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Polaryx Therapeutics in Biotechnology and Paramus
Companies Similar to Polaryx Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Polaryx Therapeutics Funding FAQs
What does Polaryx Therapeutics do?
Polaryx Therapeutics is a biotechnology company that focuses on developing treatments for diseases. The company conducts research to discover new drugs and therapies. It works on understanding the biology of different health conditions to find effective solutions. The company uses laboratory techniques and clinical studies to test its potential treatments. It aims to improve health outcomes through scientific advancements.
How much funding has Polaryx Therapeutics raised?
Polaryx Therapeutics has raised $10.0M across 1 round on record. The most recent is an undisclosed round of $10.0M announced in May 2026.
When did Polaryx Therapeutics last raise funding?
Polaryx Therapeutics' most recent funding round on record is an undisclosed round of $10.0M, announced in May 2026.
Who founded Polaryx Therapeutics?
FundedIQ lists Alex Yang (Founder) at Polaryx Therapeutics.
Where is Polaryx Therapeutics headquartered?
Polaryx Therapeutics is based in Paramus, New Jersey, United States.
How many employees does Polaryx Therapeutics have?
Polaryx Therapeutics is in the 11-50 employee band.
How does Polaryx Therapeutics' funding compare to other Biotechnology startups?
Polaryx Therapeutics' latest round of $10.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Polaryx Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Polaryx Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.